We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AKESOgen and London Genetics International Alliance to Enhance Drug Development Through Pharmacogenetics and Related Services
News

AKESOgen and London Genetics International Alliance to Enhance Drug Development Through Pharmacogenetics and Related Services

AKESOgen and London Genetics International Alliance to Enhance Drug Development Through Pharmacogenetics and Related Services
News

AKESOgen and London Genetics International Alliance to Enhance Drug Development Through Pharmacogenetics and Related Services

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "AKESOgen and London Genetics International Alliance to Enhance Drug Development Through Pharmacogenetics and Related Services"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The alliance combines world-class expertise and American-European infrastructure to support biopharma drug development. Financial terms were not disclosed.

"Our expertise in pharmacogenetic strategy development combined with a professional genomics services company that operates to CLIA standards will make this strategic alliance beneficial to both companies as it will increase our scope of possible services into the Americas with highly qualified and service oriented scientists. This represents our first deal following our acquisition by LSBC which from our side was a critical step for making this happen", said Elizabeth Foot, VP Personalised Medicine and Nutrition, London Genetics International.

Under the alliance, AKESOgen and London Genetics International will collaborate to help biopharma companies take advantage of pharmacogenetic solutions, including novel biomarker and assay development services. By providing biopharma companies with strategic advice on the application of pharmacogenetics and innovative pharmacogenetics solutions, AKESOgen and London Genetics can help customers access additional resources and speed the delivery of targeted treatments.

Advertisement